Associations among frailty and quality of life in older patients with cancer treated with chemotherapy
Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Crowder, Sylvia L. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022 |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection - Vidana, B. ELSEVIER, 2019, cancer and aging research, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:13 ; year:2022 ; number:8 ; pages:1149-1155 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jgo.2022.08.010 |
|---|
| Katalog-ID: |
ELV059539224 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV059539224 | ||
| 003 | DE-627 | ||
| 005 | 20230625013721.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221219s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jgo.2022.08.010 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica |
| 035 | |a (DE-627)ELV059539224 | ||
| 035 | |a (ELSEVIER)S1879-4068(22)00201-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.47 |2 bkl | ||
| 100 | 1 | |a Crowder, Sylvia L. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Associations among frailty and quality of life in older patients with cancer treated with chemotherapy |
| 264 | 1 | |c 2022 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of this study was to evaluate frailty prior to receipt of moderately- or highly-emetogenic chemotherapy and acute changes in QOL in patients at least 65 years of age. It was hypothesized that frail patients would report greater declines in QOL. | ||
| 700 | 1 | |a Hoogland, Aasha I. |4 oth | |
| 700 | 1 | |a Small, Brent J. |4 oth | |
| 700 | 1 | |a Carpenter, Kristen M. |4 oth | |
| 700 | 1 | |a Fischer, Stacy M. |4 oth | |
| 700 | 1 | |a Li, Daneng |4 oth | |
| 700 | 1 | |a Kinney, Anita Y. |4 oth | |
| 700 | 1 | |a Welniak, Taylor L. |4 oth | |
| 700 | 1 | |a Brownstein, Naomi |4 oth | |
| 700 | 1 | |a Reich, Richard R. |4 oth | |
| 700 | 1 | |a Hembree, Tim |4 oth | |
| 700 | 1 | |a Extermann, Martine |4 oth | |
| 700 | 1 | |a Kim, Richard |4 oth | |
| 700 | 1 | |a Afiat, Thanh-Phuong |4 oth | |
| 700 | 1 | |a Berry, Donna L. |4 oth | |
| 700 | 1 | |a Turner, Kea |4 oth | |
| 700 | 1 | |a Jim, Heather S.L. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Vidana, B. ELSEVIER |t Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection |d 2019 |d cancer and aging research |g Amsterdam [u.a.] |w (DE-627)ELV00348257X |
| 773 | 1 | 8 | |g volume:13 |g year:2022 |g number:8 |g pages:1149-1155 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jgo.2022.08.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.47 |j Pathologie |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 13 |j 2022 |e 8 |h 1149-1155 |g 7 | ||
| author_variant |
s l c sl slc |
|---|---|
| matchkey_str |
crowdersylvialhooglandaashaismallbrentjc:2022----:soitosmnfalynqaiyfienleptetwtcnet |
| hierarchy_sort_str |
2022 |
| bklnumber |
44.47 |
| publishDate |
2022 |
| allfields |
10.1016/j.jgo.2022.08.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica (DE-627)ELV059539224 (ELSEVIER)S1879-4068(22)00201-6 DE-627 ger DE-627 rakwb eng 610 VZ 44.47 bkl Crowder, Sylvia L. verfasserin aut Associations among frailty and quality of life in older patients with cancer treated with chemotherapy 2022 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of this study was to evaluate frailty prior to receipt of moderately- or highly-emetogenic chemotherapy and acute changes in QOL in patients at least 65 years of age. It was hypothesized that frail patients would report greater declines in QOL. Hoogland, Aasha I. oth Small, Brent J. oth Carpenter, Kristen M. oth Fischer, Stacy M. oth Li, Daneng oth Kinney, Anita Y. oth Welniak, Taylor L. oth Brownstein, Naomi oth Reich, Richard R. oth Hembree, Tim oth Extermann, Martine oth Kim, Richard oth Afiat, Thanh-Phuong oth Berry, Donna L. oth Turner, Kea oth Jim, Heather S.L. oth Enthalten in Elsevier Science Vidana, B. ELSEVIER Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection 2019 cancer and aging research Amsterdam [u.a.] (DE-627)ELV00348257X volume:13 year:2022 number:8 pages:1149-1155 extent:7 https://doi.org/10.1016/j.jgo.2022.08.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.47 Pathologie Medizin VZ AR 13 2022 8 1149-1155 7 |
| spelling |
10.1016/j.jgo.2022.08.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica (DE-627)ELV059539224 (ELSEVIER)S1879-4068(22)00201-6 DE-627 ger DE-627 rakwb eng 610 VZ 44.47 bkl Crowder, Sylvia L. verfasserin aut Associations among frailty and quality of life in older patients with cancer treated with chemotherapy 2022 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of this study was to evaluate frailty prior to receipt of moderately- or highly-emetogenic chemotherapy and acute changes in QOL in patients at least 65 years of age. It was hypothesized that frail patients would report greater declines in QOL. Hoogland, Aasha I. oth Small, Brent J. oth Carpenter, Kristen M. oth Fischer, Stacy M. oth Li, Daneng oth Kinney, Anita Y. oth Welniak, Taylor L. oth Brownstein, Naomi oth Reich, Richard R. oth Hembree, Tim oth Extermann, Martine oth Kim, Richard oth Afiat, Thanh-Phuong oth Berry, Donna L. oth Turner, Kea oth Jim, Heather S.L. oth Enthalten in Elsevier Science Vidana, B. ELSEVIER Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection 2019 cancer and aging research Amsterdam [u.a.] (DE-627)ELV00348257X volume:13 year:2022 number:8 pages:1149-1155 extent:7 https://doi.org/10.1016/j.jgo.2022.08.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.47 Pathologie Medizin VZ AR 13 2022 8 1149-1155 7 |
| allfields_unstemmed |
10.1016/j.jgo.2022.08.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica (DE-627)ELV059539224 (ELSEVIER)S1879-4068(22)00201-6 DE-627 ger DE-627 rakwb eng 610 VZ 44.47 bkl Crowder, Sylvia L. verfasserin aut Associations among frailty and quality of life in older patients with cancer treated with chemotherapy 2022 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of this study was to evaluate frailty prior to receipt of moderately- or highly-emetogenic chemotherapy and acute changes in QOL in patients at least 65 years of age. It was hypothesized that frail patients would report greater declines in QOL. Hoogland, Aasha I. oth Small, Brent J. oth Carpenter, Kristen M. oth Fischer, Stacy M. oth Li, Daneng oth Kinney, Anita Y. oth Welniak, Taylor L. oth Brownstein, Naomi oth Reich, Richard R. oth Hembree, Tim oth Extermann, Martine oth Kim, Richard oth Afiat, Thanh-Phuong oth Berry, Donna L. oth Turner, Kea oth Jim, Heather S.L. oth Enthalten in Elsevier Science Vidana, B. ELSEVIER Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection 2019 cancer and aging research Amsterdam [u.a.] (DE-627)ELV00348257X volume:13 year:2022 number:8 pages:1149-1155 extent:7 https://doi.org/10.1016/j.jgo.2022.08.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.47 Pathologie Medizin VZ AR 13 2022 8 1149-1155 7 |
| allfieldsGer |
10.1016/j.jgo.2022.08.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica (DE-627)ELV059539224 (ELSEVIER)S1879-4068(22)00201-6 DE-627 ger DE-627 rakwb eng 610 VZ 44.47 bkl Crowder, Sylvia L. verfasserin aut Associations among frailty and quality of life in older patients with cancer treated with chemotherapy 2022 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of this study was to evaluate frailty prior to receipt of moderately- or highly-emetogenic chemotherapy and acute changes in QOL in patients at least 65 years of age. It was hypothesized that frail patients would report greater declines in QOL. Hoogland, Aasha I. oth Small, Brent J. oth Carpenter, Kristen M. oth Fischer, Stacy M. oth Li, Daneng oth Kinney, Anita Y. oth Welniak, Taylor L. oth Brownstein, Naomi oth Reich, Richard R. oth Hembree, Tim oth Extermann, Martine oth Kim, Richard oth Afiat, Thanh-Phuong oth Berry, Donna L. oth Turner, Kea oth Jim, Heather S.L. oth Enthalten in Elsevier Science Vidana, B. ELSEVIER Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection 2019 cancer and aging research Amsterdam [u.a.] (DE-627)ELV00348257X volume:13 year:2022 number:8 pages:1149-1155 extent:7 https://doi.org/10.1016/j.jgo.2022.08.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.47 Pathologie Medizin VZ AR 13 2022 8 1149-1155 7 |
| allfieldsSound |
10.1016/j.jgo.2022.08.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica (DE-627)ELV059539224 (ELSEVIER)S1879-4068(22)00201-6 DE-627 ger DE-627 rakwb eng 610 VZ 44.47 bkl Crowder, Sylvia L. verfasserin aut Associations among frailty and quality of life in older patients with cancer treated with chemotherapy 2022 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of this study was to evaluate frailty prior to receipt of moderately- or highly-emetogenic chemotherapy and acute changes in QOL in patients at least 65 years of age. It was hypothesized that frail patients would report greater declines in QOL. Hoogland, Aasha I. oth Small, Brent J. oth Carpenter, Kristen M. oth Fischer, Stacy M. oth Li, Daneng oth Kinney, Anita Y. oth Welniak, Taylor L. oth Brownstein, Naomi oth Reich, Richard R. oth Hembree, Tim oth Extermann, Martine oth Kim, Richard oth Afiat, Thanh-Phuong oth Berry, Donna L. oth Turner, Kea oth Jim, Heather S.L. oth Enthalten in Elsevier Science Vidana, B. ELSEVIER Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection 2019 cancer and aging research Amsterdam [u.a.] (DE-627)ELV00348257X volume:13 year:2022 number:8 pages:1149-1155 extent:7 https://doi.org/10.1016/j.jgo.2022.08.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.47 Pathologie Medizin VZ AR 13 2022 8 1149-1155 7 |
| language |
English |
| source |
Enthalten in Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection Amsterdam [u.a.] volume:13 year:2022 number:8 pages:1149-1155 extent:7 |
| sourceStr |
Enthalten in Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection Amsterdam [u.a.] volume:13 year:2022 number:8 pages:1149-1155 extent:7 |
| format_phy_str_mv |
Article |
| bklname |
Pathologie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection |
| authorswithroles_txt_mv |
Crowder, Sylvia L. @@aut@@ Hoogland, Aasha I. @@oth@@ Small, Brent J. @@oth@@ Carpenter, Kristen M. @@oth@@ Fischer, Stacy M. @@oth@@ Li, Daneng @@oth@@ Kinney, Anita Y. @@oth@@ Welniak, Taylor L. @@oth@@ Brownstein, Naomi @@oth@@ Reich, Richard R. @@oth@@ Hembree, Tim @@oth@@ Extermann, Martine @@oth@@ Kim, Richard @@oth@@ Afiat, Thanh-Phuong @@oth@@ Berry, Donna L. @@oth@@ Turner, Kea @@oth@@ Jim, Heather S.L. @@oth@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV00348257X |
| dewey-sort |
3610 |
| id |
ELV059539224 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV059539224</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625013721.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221219s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jgo.2022.08.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV059539224</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1879-4068(22)00201-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.47</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Crowder, Sylvia L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Associations among frailty and quality of life in older patients with cancer treated with chemotherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of this study was to evaluate frailty prior to receipt of moderately- or highly-emetogenic chemotherapy and acute changes in QOL in patients at least 65 years of age. It was hypothesized that frail patients would report greater declines in QOL.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hoogland, Aasha I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Small, Brent J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carpenter, Kristen M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fischer, Stacy M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Daneng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kinney, Anita Y.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Welniak, Taylor L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brownstein, Naomi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reich, Richard R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hembree, Tim</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Extermann, Martine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Afiat, Thanh-Phuong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berry, Donna L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Turner, Kea</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jim, Heather S.L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Vidana, B. ELSEVIER</subfield><subfield code="t">Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection</subfield><subfield code="d">2019</subfield><subfield code="d">cancer and aging research</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00348257X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:8</subfield><subfield code="g">pages:1149-1155</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jgo.2022.08.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.47</subfield><subfield code="j">Pathologie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2022</subfield><subfield code="e">8</subfield><subfield code="h">1149-1155</subfield><subfield code="g">7</subfield></datafield></record></collection>
|
| author |
Crowder, Sylvia L. |
| spellingShingle |
Crowder, Sylvia L. ddc 610 bkl 44.47 Associations among frailty and quality of life in older patients with cancer treated with chemotherapy |
| authorStr |
Crowder, Sylvia L. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00348257X |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.47 bkl Associations among frailty and quality of life in older patients with cancer treated with chemotherapy |
| topic |
ddc 610 bkl 44.47 |
| topic_unstemmed |
ddc 610 bkl 44.47 |
| topic_browse |
ddc 610 bkl 44.47 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a i h ai aih b j s bj bjs k m c km kmc s m f sm smf d l dl a y k ay ayk t l w tl tlw n b nb r r r rr rrr t h th m e me r k rk t p a tpa d l b dl dlb k t kt h s j hs hsj |
| hierarchy_parent_title |
Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection |
| hierarchy_parent_id |
ELV00348257X |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV00348257X |
| title |
Associations among frailty and quality of life in older patients with cancer treated with chemotherapy |
| ctrlnum |
(DE-627)ELV059539224 (ELSEVIER)S1879-4068(22)00201-6 |
| title_full |
Associations among frailty and quality of life in older patients with cancer treated with chemotherapy |
| author_sort |
Crowder, Sylvia L. |
| journal |
Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection |
| journalStr |
Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| container_start_page |
1149 |
| author_browse |
Crowder, Sylvia L. |
| container_volume |
13 |
| physical |
7 |
| class |
610 VZ 44.47 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Crowder, Sylvia L. |
| doi_str_mv |
10.1016/j.jgo.2022.08.010 |
| dewey-full |
610 |
| title_sort |
associations among frailty and quality of life in older patients with cancer treated with chemotherapy |
| title_auth |
Associations among frailty and quality of life in older patients with cancer treated with chemotherapy |
| abstract |
Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of this study was to evaluate frailty prior to receipt of moderately- or highly-emetogenic chemotherapy and acute changes in QOL in patients at least 65 years of age. It was hypothesized that frail patients would report greater declines in QOL. |
| abstractGer |
Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of this study was to evaluate frailty prior to receipt of moderately- or highly-emetogenic chemotherapy and acute changes in QOL in patients at least 65 years of age. It was hypothesized that frail patients would report greater declines in QOL. |
| abstract_unstemmed |
Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of this study was to evaluate frailty prior to receipt of moderately- or highly-emetogenic chemotherapy and acute changes in QOL in patients at least 65 years of age. It was hypothesized that frail patients would report greater declines in QOL. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
8 |
| title_short |
Associations among frailty and quality of life in older patients with cancer treated with chemotherapy |
| url |
https://doi.org/10.1016/j.jgo.2022.08.010 |
| remote_bool |
true |
| author2 |
Hoogland, Aasha I. Small, Brent J. Carpenter, Kristen M. Fischer, Stacy M. Li, Daneng Kinney, Anita Y. Welniak, Taylor L. Brownstein, Naomi Reich, Richard R. Hembree, Tim Extermann, Martine Kim, Richard Afiat, Thanh-Phuong Berry, Donna L. Turner, Kea Jim, Heather S.L. |
| author2Str |
Hoogland, Aasha I. Small, Brent J. Carpenter, Kristen M. Fischer, Stacy M. Li, Daneng Kinney, Anita Y. Welniak, Taylor L. Brownstein, Naomi Reich, Richard R. Hembree, Tim Extermann, Martine Kim, Richard Afiat, Thanh-Phuong Berry, Donna L. Turner, Kea Jim, Heather S.L. |
| ppnlink |
ELV00348257X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.jgo.2022.08.010 |
| up_date |
2024-07-06T22:18:18.186Z |
| _version_ |
1803869799775731712 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV059539224</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625013721.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221219s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jgo.2022.08.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001975.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV059539224</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1879-4068(22)00201-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.47</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Crowder, Sylvia L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Associations among frailty and quality of life in older patients with cancer treated with chemotherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of this study was to evaluate frailty prior to receipt of moderately- or highly-emetogenic chemotherapy and acute changes in QOL in patients at least 65 years of age. It was hypothesized that frail patients would report greater declines in QOL.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hoogland, Aasha I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Small, Brent J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carpenter, Kristen M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fischer, Stacy M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Daneng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kinney, Anita Y.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Welniak, Taylor L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brownstein, Naomi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reich, Richard R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hembree, Tim</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Extermann, Martine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Afiat, Thanh-Phuong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berry, Donna L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Turner, Kea</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jim, Heather S.L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Vidana, B. ELSEVIER</subfield><subfield code="t">Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection</subfield><subfield code="d">2019</subfield><subfield code="d">cancer and aging research</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00348257X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:8</subfield><subfield code="g">pages:1149-1155</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jgo.2022.08.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.47</subfield><subfield code="j">Pathologie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2022</subfield><subfield code="e">8</subfield><subfield code="h">1149-1155</subfield><subfield code="g">7</subfield></datafield></record></collection>
|
| score |
7.398551 |